Jazz Pharmaceuticals plc
JAZZ
$181.37
-$0.65-0.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -163.58% | -179.56% | -202.51% | 45.77% | 35.02% |
| Total Depreciation and Amortization | 5.49% | 5.33% | 3.76% | 2.61% | 3.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 294.83% | 365.33% | 479.58% | 13.32% | 3.92% |
| Change in Net Operating Assets | 124.63% | 106.58% | 17.30% | 193.04% | 62.47% |
| Cash from Operations | -2.88% | 19.50% | 22.63% | 50.06% | 27.83% |
| Capital Expenditure | -54.33% | -58.55% | -79.33% | -66.57% | -58.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.15% | -134.35% | 120.91% | 10.65% | -237.98% |
| Cash from Investing | -197.11% | -524.58% | -31.20% | 5.79% | -211.66% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -28.88% | -28.88% | -4,274.19% | -4,274.19% | -1,854.84% |
| Issuance of Common Stock | 422.41% | 56.98% | 20.77% | 22.84% | -55.56% |
| Repurchase of Common Stock | 45.76% | 56.65% | 10.53% | -18.46% | -15.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4,357.07% | -1,238.31% | -76.53% | -121.79% | 106.72% |
| Foreign Exchange rate Adjustments | 491.34% | 76.15% | 521.42% | 292.60% | -247.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -212.62% | -201.09% | -325.75% | 51.94% | 45.09% |